Eviplera TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: tenofovir disoproxil + emtricitabine + rilpivirine
Pack: Eviplera tablet, 30, bottle
Brand name
(ARTG)
: EVIPLERA tenofovir disoproxil fumarate 300 mg /emtricitabine 200 mg /rilpivirine (as HCl) 25 mg tablet bottleDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
EVIPLERA is indicated for the treatment of HIV infection in treatment-naïve adult patients with plasma HIV-1 RNA =< 100,000 copies/mL at the start of therapy. EVIPLERA is also indicated in certain virologically-suppressed (HIV-1 RNA <50 copies/mL) adult patients on a stable antiretroviral regimen at start of therapy in order to replace their current antiretroviral treatment regimen (see CLINICAL TRIALS). Patients must not have a history of resistance to any of the components of EVIPLERA (tenofovir DF, emtricitabine or rilpivirine).
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet, film coated
- Oral
- Purplish-pink, capsule-shaped film-coated tablet; debossed with 'GSI' on one side, and plain faced on the other side
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 30 tablets/bottle pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient tenofovir disoproxil + emtricitabine + rilpivirine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
